La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Coloplast Gestione
Gestione criteri di controllo 4/4
Coloplast's Il CEO è Kristian Villumsen, nominato in Dec2018, e ha un mandato di 5.67 anni. la retribuzione annua totale è DKK 23.30M, composta da 51.5% di stipendio e 48.5% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.045% delle azioni della società, per un valore di DKK 94.65M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 6.3 anni e 6.6 anni.
Informazioni chiave
Kristian Villumsen
Amministratore delegato
DKK 23.3m
Compenso totale
Percentuale dello stipendio del CEO | 51.5% |
Mandato del CEO | 5.7yrs |
Proprietà del CEO | 0.05% |
Durata media del management | 6.3yrs |
Durata media del Consiglio di amministrazione | 6.6yrs |
Aggiornamenti recenti sulla gestione
Here's Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Looks Fair for the time being
Nov 25Recent updates
Subdued Growth No Barrier To Coloplast A/S' (CPH:COLO B) Price
Jul 17These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well
Jun 29Coloplast's (CPH:COLO B) Solid Earnings May Rest On Weak Foundations
May 21Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of DKK5.00
May 10Analyst Estimates: Here's What Brokers Think Of Coloplast A/S (CPH:COLO B) After Its Interim Report
May 09A Look At The Fair Value Of Coloplast A/S (CPH:COLO B)
Apr 26There's Reason For Concern Over Coloplast A/S' (CPH:COLO B) Price
Apr 08Is Coloplast (CPH:COLO B) A Risky Investment?
Mar 21Estimating The Intrinsic Value Of Coloplast A/S (CPH:COLO B)
Jan 09Coloplast A/S' (CPH:COLO B) Price Is Out Of Tune With Earnings
Dec 22These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well
Dec 04Coloplast (CPH:COLO B) Strong Profits May Be Masking Some Underlying Issues
Nov 16A Look At The Intrinsic Value Of Coloplast A/S (CPH:COLO B)
Sep 30Is Coloplast (CPH:COLO B) A Risky Investment?
Jun 28Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 18% Below Its Share Price
Jun 10Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly
Mar 22Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 25% Below Its Share Price
Mar 01These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well
Dec 14Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's
Nov 26Here's Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Looks Fair for the time being
Nov 25Coloplast's (CPH:COLO B) Shareholders Will Receive A Bigger Dividend Than Last Year
Nov 11With EPS Growth And More, Coloplast (CPH:COLO B) Makes An Interesting Case
Oct 25Estimating The Fair Value Of Coloplast A/S (CPH:COLO B)
Aug 26These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well
Jul 27Here's Why We Think Coloplast (CPH:COLO B) Is Well Worth Watching
Jul 12Is There An Opportunity With Coloplast A/S' (CPH:COLO B) 45% Undervaluation?
May 23Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of kr.5.00
May 08Coloplast (CPH:COLO B) Seems To Use Debt Rather Sparingly
Apr 13Here's Why I Think Coloplast (CPH:COLO B) Is An Interesting Stock
Mar 29Coloplast A/S (CPH:COLO B) Shares Could Be 41% Below Their Intrinsic Value Estimate
Feb 12Coloplast (CPH:COLO B) Could Easily Take On More Debt
Jan 12Is Now The Time To Put Coloplast (CPH:COLO B) On Your Watchlist?
Dec 28Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Is Not Excessive At All
Nov 25A Look At The Fair Value Of Coloplast A/S (CPH:COLO B)
Oct 31Here's Why Coloplast (CPH:COLO B) Can Manage Its Debt Responsibly
Oct 02Do Coloplast's (CPH:COLO B) Earnings Warrant Your Attention?
Sep 16Does This Valuation Of Coloplast A/S (CPH:COLO B) Imply Investors Are Overpaying?
Aug 02Analisi delle retribuzioni degli amministratori delegati
Data | Compenso totale | Stipendio | Guadagni aziendali |
---|---|---|---|
Jun 30 2024 | n/a | n/a | DKK 5b |
Mar 31 2024 | n/a | n/a | DKK 5b |
Dec 31 2023 | n/a | n/a | DKK 5b |
Sep 30 2023 | DKK 23m | DKK 12m | DKK 5b |
Jun 30 2023 | n/a | n/a | DKK 5b |
Mar 31 2023 | n/a | n/a | DKK 5b |
Dec 31 2022 | n/a | n/a | DKK 5b |
Sep 30 2022 | DKK 21m | DKK 12m | DKK 5b |
Jun 30 2022 | n/a | n/a | DKK 5b |
Mar 31 2022 | n/a | n/a | DKK 5b |
Dec 31 2021 | n/a | n/a | DKK 5b |
Sep 30 2021 | DKK 22m | DKK 11m | DKK 5b |
Jun 30 2021 | n/a | n/a | DKK 5b |
Mar 31 2021 | n/a | n/a | DKK 4b |
Dec 31 2020 | n/a | n/a | DKK 4b |
Sep 30 2020 | DKK 20m | DKK 11m | DKK 4b |
Jun 30 2020 | n/a | n/a | DKK 4b |
Mar 31 2020 | n/a | n/a | DKK 4b |
Dec 31 2019 | n/a | n/a | DKK 4b |
Sep 30 2019 | DKK 17m | DKK 10m | DKK 4b |
Jun 30 2019 | n/a | n/a | DKK 4b |
Mar 31 2019 | n/a | n/a | DKK 4b |
Dec 31 2018 | n/a | n/a | DKK 4b |
Sep 30 2018 | DKK 11m | DKK 6m | DKK 4b |
Jun 30 2018 | n/a | n/a | DKK 4b |
Mar 31 2018 | n/a | n/a | DKK 4b |
Dec 31 2017 | n/a | n/a | DKK 4b |
Sep 30 2017 | DKK 10m | DKK 6m | DKK 4b |
Compensazione vs Mercato: La retribuzione totale di Kristian ($USD 3.46M ) è circa la media per le aziende di dimensioni simili nel mercato Danish ($USD 3.69M ).
Compensazione vs guadagni: La retribuzione di Kristian è stata coerente con le performance aziendali dell'ultimo anno.
AMMINISTRATORE DELEGATO
Kristian Villumsen (54 yo)
5.7yrs
Mandato
DKK 23,300,000
Compensazione
Mr. Kristian Villumsen has been Independent Director of Demant A/S since March 5, 2021. He has been the President and Chief Executive Officer of Coloplast A/S since December 4, 2018. Mr. Villumsen was an E...
Gruppo dirigente
Nome | Posizione | Mandato | Compensazione | Proprietà |
---|---|---|---|---|
President & CEO | 5.7yrs | DKK 23.30m | 0.045% DKK 89.9m | |
Executive VP & CFO | 10.1yrs | DKK 11.90m | 0.0012% DKK 2.4m | |
Executive Vice President of Global Operations | 10.1yrs | DKK 10.50m | Nessun dato | |
Executive Vice President of Innovation | no data | DKK 10.00m | Nessun dato | |
Executive Vice President of Growth | 5.6yrs | DKK 12.00m | Nessun dato | |
Senior Controller & Employees Representative Director | no data | DKK 450.00k | 0.000020% DKK 39.9k | |
Vice President of Investor Relations | 7.8yrs | Nessun dato | Nessun dato | |
Director of Corporate Communications | no data | Nessun dato | Nessun dato | |
Senior Vice President of People & Culture | 2.6yrs | Nessun dato | Nessun dato | |
Senior Vice President of Sales Europe | 12.3yrs | Nessun dato | Nessun dato | |
Senior Vice President of Wound & Skin Care | 3.9yrs | Nessun dato | Nessun dato | |
Senior Vice President of Chronic Care - North America | 6.3yrs | Nessun dato | Nessun dato |
6.3yrs
Durata media
55yo
Età media
Gestione esperta: Il team dirigenziale di COLO B è esperto e expertise (durata media dell'incarico 6.3 anni).
Membri del Consiglio di amministrazione
Nome | Posizione | Mandato | Compensazione | Proprietà |
---|---|---|---|---|
Senior Controller & Employees Representative Director | 18.6yrs | DKK 450.00k | 0.000020% DKK 39.9k | |
Independent Director | 6.7yrs | DKK 690.00k | 0.0027% DKK 5.3m | |
Chairman of the Board | 5.7yrs | DKK 1.84m | 0.092% DKK 184.1m | |
Deputy Chairman | 56.6yrs | DKK 938.00k | 1.93% DKK 3.8b | |
Independent Director | 3.7yrs | DKK 880.00k | 0.00022% DKK 439.1k | |
Independent Director | 8.7yrs | DKK 600.00k | Nessun dato | |
Employees Representative Director | 6.6yrs | DKK 450.00k | Nessun dato | |
Employees Representative Director | 6.6yrs | DKK 450.00k | 0.00072% DKK 1.4m | |
Independent Director | 2.7yrs | DKK 600.00k | Nessun dato |
6.6yrs
Durata media
59yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di COLO B sono considerati esperti (durata media dell'incarico 6.6 anni).